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Abstract
Excessive accumulation of bone marrow adipocytes observed in senile osteoporosis or age-related osteopenia is caused by
the unbalanced differentiation of MSCs into bone marrow adipocytes or osteoblasts. Several transcription factors are known
to regulate the balance between adipocyte and osteoblast differentiation. However, the molecular mechanisms that
regulate the balance between adipocyte and osteoblast differentiation in the bone marrow have yet to be elucidated. To
identify candidate genes associated with senile osteoporosis, we performed genome-wide expression analyses of
differentiating osteoblasts and adipocytes. Among transcription factors that were enriched in the early phase of
differentiation, Id4 was identified as a key molecule affecting the differentiation of both cell types. Experiments using bone
marrow-derived stromal cell line ST2 and Id4-deficient mice showed that lack of Id4 drastically reduces osteoblast
differentiation and drives differentiation toward adipocytes. On the other hand knockdown of Id4 in adipogenic-induced
ST2 cells increased the expression of Pparc2, a master regulator of adipocyte differentiation. Similar results were observed in
bone marrow cells of femur and tibia of Id4-deficient mice. However the effect of Id4 on Pparc2 and adipocyte
differentiation is unlikely to be of direct nature. The mechanism of Id4 promoting osteoblast differentiation is associated
with the Id4-mediated release of Hes1 from Hes1-Hey2 complexes. Hes1 increases the stability and transcriptional activity of
Runx2, a key molecule of osteoblast differentiation, which results in an enhanced osteoblast-specific gene expression. The
new role of Id4 in promoting osteoblast differentiation renders it a target for preventing the onset of senile osteoporosis.
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Introduction
Senile osteoporosis or age-related osteopenia is accompanied by
increased bone marrow tissue adiposity [1]. Bone marrow adipocytes
and osteoblasts are thought to originate from common mesenchymal
stem cells (MSCs). Therefore, it has been suggested that the excessive
accumulation of marrow adipocytes following bone loss is caused by
unbalanced differentiation of MSCs into marrow adipocytes and
osteoblasts [2]. Support for this hypothesis comes from studies of
peroxisome proliferators-activated receptor-c (Pparc), a master regulator of
adipocyte differentiation, deficient embryonic stem cellsthat showed an
increase in osteoblast differentiation [3]. In contrast, calvarial adipocyte
differentiation is augmented when runt-related transcription factor 2 (Runx2),
a master regulator of osteoblast differentiation has been knocked out
[4]. Transcription factors Runx2 and Sp7 transcription factor 7 (Sp7)
regulate MSC commitment to osteoblast differentiation along with
bone morphogenetic protein (BMP) signaling pathway [5]. Conversely,
Pparc and CCAAT/enhancer binding protein (C/EBP) transcription
factor family members drive MSCs differentiation toward adipocytes
[6]. Other proteins that regulate the balance between adipocyte and
osteoblast differentiation are tafazzin, Wnt5a, Wnt10b, Msx2, C/
EBPband basic helix-loop-helix (bHLH) family member e40 (Bhlhe40)
[6–8]. Aforementioned transcription factors suppress adipocyte
differentiation and promote osteoblast differentiation. Regardless of
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balance between osteoblast and adipocyte differentiation in the bone
marrow has yet to be elucidated. Hence, we aimed to identify
transcription factors that regulate the direction of differentiation toward
osteoblast or adipocyte by analyzing their genome-wide expression
profiles in differentiation time series experiments.
We noticed in early phases a subgroup of transcription factors
that appeared to function in both osteoblasts and adipocytes
differentiation. Particularly, bHLH superfamily transcription
factors were significantly enriched and up-regulated in the early
phase of osteoblast differentiation.
The bHLH superfamily comprises transcription factors that form
homo- or heterodimers and typically bind to a consensus sequence
(CANNTG) called an E-box [9]. It is well known that bHLH
transcription factors play important roles in development and cell
differentiation. For example, Myod1 is a key differentiation factor of
myoblasts andSrebf1isinvolved inadipocyte differentiation [10,11].
Hairy and enhancer of split (Hes) family members of bHLH
superfamily are crucial regulators of cortical development [12].
Here, we have identified Inhibitor of DNA binding 4 (Id4),
which also belongs to the bHLH superfamily as a key molecule
that regulates the direction of differentiation toward osteoblast or
adipocyte in vitro and in vivo using genome wide expression study.
Furthermore, we established that Id4 promotes osteoblast
differentiation by enhancing Runx2 transcriptional activity
through stabilization of Runx2 protein. The new role of Id4 in
directing osteogenic and adipogenic cell fate makes it a likely
target for preventing the onset of senile osteoporosis.
Results
Genome-wide expression profile predicts Id4 as a
candidate molecular switch in osteoblast and adipocyte
differentiation
To delineate the sequential changes of transcription factors
activating and repressing downstream osteogenic and/or adipo-
genic target genes, we evaluated the differentiation capability
toward both osteoblasts and adipocytes using six cell lines (ST2,
C2C12, DFAT-D1, PA6, 10T1/2, NRG). Of these, bone marrow-
derived stromal cell line ST2 differentiated most efficiently into
both osteoblasts and adipocytes (data not shown). Using
Affymetrix mouse GeneChip, we aimed to identify clusters of
transcription factors that are temporally co-regulated in one but
not in another cluster (CIBEX Accession number: CBX90). Of
1,270 transcription factors, 407 genes were significantly up- or
down- regulated in either osteoblast or adipocyte differentiation
compared to the non-induced control (Table 1 and Table S1).
Hierarchical clustering analysis of transcription factor gene
expression data at 15 osteoblast and seven adipocyte differentia-
tion time points (Figure 1A) revealed distinct clusters that represent
phases of sequentially expressed transcription factors (Figure 1B).
Differentiation into osteoblasts is characterized by five phases
(Figure S1) whereas adipocyte differentiation resulted in four
phases (Table S1). The early phases of osteoblast (1 hr) and
adipocyte (48 hr) differentiation showed the greatest variability in
transcription factor expression levels (Figure 2A and Table S1).
Chi-square testing for over-representation of transcription
factors in each differentiation phase supported only six up-
regulated bHLH superfamily members (Id1, Id2, Npas4, Id4, Hes1
and Bhlhe40) of the immediate early phase osteoblast differentia-
tion (1 hr) as significantly (p,0.01) enriched (Figure 2B). Since Id4,
Hes1 and Bhlhe40 expression increased (decreased) twofold or
greater during osteoblast (adipocyte) differentiation compared to
the control (Figure 2C and Table 2), these transcription factors are
likely to play a pivotal role in the regulation of osteoblast and
adipocyte differentiation.
Indeed, Hes1 and Bhlhe40 are known to be involved in both
differentiation pathways [8,13,14], whereas Id4 has not yet been
implicated in either differentiation pathways. Additionally, Id4
expression patterns in osteoblast and adipocyte differentiation
were also compared by quantitative real-time PCR (qRT-PCR).
Expression of Id4 significantly increased during osteoblast
differentiation, attained a peak on day 4 and decreased thereafter
(Figure S2A). In contrast, Id4 expression decreased during
adipocyte differentiation (Figure S2B). Expression levels of Id1
and Id2 were also up-regulated in the early stage (1 hr) of
osteoblast differentiation, but thereafter their expression dropped
Author Summary
Increased bone marrow adiposity is observed in the bone
marrow of senile osteoporosis patients. This is caused by
unbalanced differentiation of mesenchymal stem cells
(MSCs) into osteoblast or adipocyte. Previous reports have
indicated that several transcription factors play important
roles in determining the direction of MSCs differentiation
into osteoblast or adipocyte. So far, little is known about
the overall dynamics and regulation of transcription factor
expression changes leading to the imbalance of osteoblast
and adipocyte differentiation inside the bone marrow. We
have performed genome-wide gene expression analyses
during the differentiation of MSCs into osteoblast or
adipocyte. We identified basic helix-loop-helix transcrip-
tion factor family member Id4 as a leading candidate
controlling the differentiation toward adipocyte or osteo-
blast. Suppression of Id4 expression in MSCs repressed
osteoblast differentiation and increased adipocyte differ-
entiation. In contrast, overexpression of Id4 in MSCs
promoted osteoblast differentiation and attenuated adi-
pocyte differentiation. Moreover, Id4-mutant mice showed
abnormal accumulation of lipid droplets in bone marrow
and impaired bone formation activity. In summary, we
have demonstrated a molecular function of Id4 in
osteoblast differentiation. The findings revealed that Id4
is a molecular switch enhancing osteoblast differentiation
at the expense of adipocyte differentiation.
Table 1. Expression behavior of 1,270 transcription factors
selected from all mouse genes (Ensembl release 52) based on
GO IDs (Table 3) during osteoblast and adipocyte
differentiation.
Transcription
Factors
Osteoblast
Differentiation
q Q qQ < Total
Adipocyte
Differentiation
q 22 6 4 70 102
Q 25 40 21 132 218
qQ 35 2 2 1 2
< 42 26 7 863 938
Total 92 77 34 1,067 1,270
Arrows indicate up- (q), down-regulated (Q), or up- and down-regulated
(qQ) transcription factors. No change in expression is symbolized by the
almost equal sign (<).
doi:10.1371/journal.pgen.1001019.t001
Id4 Promotes Osteoblast Differentiation
PLoS Genetics | www.plosgenetics.org 2 July 2010 | Volume 6 | Issue 7 | e1001019to base levels (Figure 2C, upper panel). Therefore, we hypothe-
sized that Id4 may act as a novel molecular switch in osteoblast
and adipocyte differentiation.
Aside from Id4, Hes1 and Bhlhe40, we identified additional
bHLH members and various hypothetical and non-bHLH
transcription factors as phase-specific candidate regulators of
Figure 1. Transcription factor gene expression framework of differentiating ST2 cells. (A) Time-course sampling for gene expression
analyses in ST2 cells. Vertical bars crossing the gradated blue and orange arrows indicate the sampling times during osteoblast and adipocyte
differentiation, respectively. Five blue (osteoblasts) and four orange (adipocytes) boxes indicate the hierarchical clustering-derived phases of
differentiation. (B) Gene expression heat map and clustering results of 1,270 transcription factors in 22 time-course samples.
doi:10.1371/journal.pgen.1001019.g001
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in Table S1 await further functional characterization regarding
their involvement in osteoblast and/or adipocyte differentiation.
Id4 knockdown suppresses osteoblast differentiation of
MSCs, and overexpression promotes osteoblast
differentiation
To evaluate the potential role of Id4 in ST2 osteoblast
differentiation, Id4 was suppressed by siRNA knockdown. As shown
in Figure 3A, Id4 siRNA (siId4)-treated ST2 cells differentiating into
osteoblasts showed a significant decrease in Id4 expression. The
decline of Id4 expression was accompanied by weak alkaline
phosphatase (ALP) activity and reduced bone c carboxyglutamate protein
1 (Bglap1 also called osteocalcin) expression (Figure 3B and 3C). Since
both are markers of osteoblast differentiation, it appeared that Id4 is
important in osteoblast differentiation of MSCs. We next evaluated
whether forced expression of Id4 can promote osteoblast differen-
tiation in MSCs by retroviral systems (Figure 3D). ST2 cells infected
with Id4 recombinant retrovirus showed increased expression levels
of ALP and Bglap1 compared to cells infected with control virus
independentofthepresenceorabsenceofBMP4(Figure3Eand3F).
Taken together, Id4 promotes osteoblast differentiation of MSCs.
Id4 knockdown stimulates adipocyte differentiation, and
overexpression attenuates lipid accumulation
Id4 knockdown in adipogenesis-induced ST2 cells (Figure 4A)
significantly increased expression levels of other adipogenic
marker genes such as Pparc2 [15] and Adipoq [16] (Figure 4B
and 4C). Concomitantly, the number of Oil Red O stained lipid
droplets and triglyceride levels also increased (Figure 4D and 4E).
Forced expression of Id4 was confirmed by transfection into Cos7
cells with Id4 expression vector (Figure 4F). Adipocytes differen-
tiated from ST2 cells transfected with Id4 expression vector
showed slightly but significantly decreased lipid accumulation
compared to empty vector transfectants (Figure 4G). The
combined results of Id4 siRNA knockdown and overexpression
in ST2 suggest that Id4 attenuates differentiation of MSCs into
adipocytes.
Id4-knockout mice (Id4
2/2) showed impaired osteoblast
differentiation
Previously Id4
2/2 mice were studied only in context of neural
development [17]. We confirmed that Id4 expression was highest
in the brain followed by cortical bone, kidney, thymus and bone
marrow of C57BL/6J mice (Figure 5A). The body length and
weight of 4 weeks old Id4
2/2 mice was 13–15% shorter and 35–
40% lower compared to wild-type (Id4
+/+) littermates (Figure 5B
and 5C). Id4
2/2 mice showed severe growth retardation and died
by 5 weeks. In addition, we observed visible skeletal phenotypes of
Id4
2/2 mice, but no skeletal deformities (data not shown).
Altogether, our data hint at an important role of Id4 in bone
formation.
Bone histological analysis of Id4
2/2 mice revealed significantly
decreased bone volume (BV) in the 6
th lumbar (Figure 5D and 5E).
Table 2. Expression of eleven bHLH transcription factors shown in Figure 2A.
Differentiation Differentiation Clusters
Gene Symbol Osteoblast Adipocyte Osteoblast Adipocyte
Bhlhe40 qQ 1h q 4d Q
Hes1 qQ 1h q 4d Q
Id1 qQ Q 1h q 10d–14d Q
Id2 qQ Q 1h q 2d Q
Id4 qQ 1h q 4d Q
Npas4 qQ Q 1h q 2d Q
Arnt2 q < 6h–24h q <
Atoh8 qQ Q 6h–24h q 2d Q
Hey1 q < 6h–24h q <
Hey2 q < 6h–24h q <
Clock qq 8d–14d q 10d–14d q
Of eleven transcription factors, Bhlhe40, Hes1 and Id4 were two-fold or greater up-regulated during osteoblast differentiation. On the other hand, these genes were one-
half fold or greater down-regulated during adipocyte differentiation. Arrows indicate up- (q), down-regulated (Q), or up- and downregulated (qQ) bHLH genes. No
change in expression is symbolized by the almost equal sign (<). Crosstalk functions between osteoblast and adipocyte differentiation have been reported for Bhlhe40
[8], Hes1 [13,14] and Id4 (this study), only.
doi:10.1371/journal.pgen.1001019.t002
Figure 2. Enrichment of bHLH family in early phase of osteoblast differentiation and their expression pattern. (A) Summary of up-
regulated transcription factors (Figure S1) associated with five phases of osteoblast differentiation. Asterisk (*): bHLH transcription factors that are
overrepresented only during the early phase of osteoblast differentiation (p,0.01, Figure 2B). Sharp (#): transcription factors known to be associated
with osteoblast differentiation and/or bone development. (B) Chi-square (x
2) test for independence of bHLH superfamily genes in the immediate
early phase (1 hr) of osteoblast differentiation. Null hypothesis: the occurrence of up-regulated bHLH transcription factors observed during the
immediate early phase of osteoblast differentiation among all genes associated with probe set of Affymetrix GeneChip Mouse Genome 430 2.0 array
is independent. Results of the contingency table (262 cells, degree of freedom=1) allowed to reject the Null hypothesis. The expression of bHLH
transcription factors was significantly up-regulated during the immediate early phase of osteoblast differentiation (p,0.01). (C) Expression pattern of
six bHLH family genes in osteoblast and adipocyte differentiation. The chart represents expression changes of six bHLH genes during osteoblast and
adipocyte differentiation. The horizontal axis indicates each time point after induction. The vertical axis indicates the logarithmic expression ratio
(base 2) of each time point in comparison to the control (0 day).
doi:10.1371/journal.pgen.1001019.g002
Id4 Promotes Osteoblast Differentiation
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2/2 mice
compared to Id4
+/+ mice (Figure 5F and 5G). The BV to total
volume ratio, BFR to bone surface (BS) ratio and mineral
apposition rate (MAR) of Id4
2/2 mice were 57.3%, 28.1% and
30.7% lower compared to Id4
+/+ mice in the 6
th lumbar,
respectively (Figure 5N–5P).
In Id4
+/+ mice, active cuboidal-shaped osteoblasts (type II
osteoblasts) were distributed in a row along the lumbar BS
(Figure 5H), whereas in the corresponding region of Id4
2/2 mice
osteoblasts were predominantly flat and resting (type IV
osteoblasts; lining cells) (Figure 5I). The number of osteoblasts as
a whole did not change significantly between Id4
+/+ and Id4
2/2
mice (data not shown). However, in Id4
2/2 mice the population of
active osteoblasts was reduced (type II, Figure 5Q), whereas
inactive osteoblasts accumulated (type IV, Figure 5R). These
findings imply that Id4 modulates both differentiation of
osteoblasts from pre-osteoblasts and regulation of osteoblast
maturation.
Impaired bone formation was also observed in the lateral
calvaria of Id4
2/2 mice (Figure 5K and 5M). In wild type mice,
osteoblasts were closely lined up along the calvarial BS (Figure 5J).
In contrast, no osteoblasts were observed along the calvarial bone
of Id4
2/2 mice (Figure 5K). The osteoid thickness, BFR to BS
ratios and MAR of Id4
2/2 mice calvarial bones were 61.5%,
49.1% and 65.2% of Id4
+/+ mice, respectively (Figure 5S, 5O, and
5P). These results suggest that Id4 is important for both
endochondorial and membranous ossification. Growth Plate
Width and Longitudinal Growth Rate (Lo. G. R) of Id4
2/2 mice
tibia were 68.4% and 57.1% of Id4
+/+ mice, respectively (Figure
S3A, S3B, S3C, S3D), which may have caused the growth
retardation of Id4
2/2 mice.
Id4 interacts with Hey2 and inhibits the transcriptional
repression of Hey2
Id family members are known to heterodimerize with other bHLH
transcriptional factors, thus inhibiting the binding to the E-box motif
[18]. To explore whether heterodimerized Id4 switches the direction of
osteoblast and adipocyte differentiation, we assayed Id4 protein-protein
interactions and analyzed their effects. Using immunoprecipitation we
attempted to capture for candidate bHLH transcription factors that
bind to Id4. Out of four tested bHLH transcription factors (Hes1,
hairy/enhancer-of-split related with YRPW motif 1; Hey1, hairy/
enhancer-of-split related with YRPW motif 2; Hey2 and Bhlhe40)
(Figure S4A), only Hey2 bound to Id4 (Figure 6A, Figure S4A and
S4B).An earlierstudy demonstrated that Hey2 isforming heterodimers
with Hes1, which then bind to the E-box motif and repress
transcription [19]. Therefore, we tested the effect of Id4 on
transcriptional repression of Hey2/Hes1 heterodimers against the E-
box element. Transcriptional repression onto E-box element in the
presence of either Hey2 or Hes1 showed no effect or 39% inhibition of
E-box transcriptional activity relative to control (empty expression
vector), respectively (Figure 6B). Although luciferase activity was lowest
in the presence of both Hey2 and Hes1, inhibition of transcriptional
repression by Id4 increased in dose-dependent manner (Figure 6B). We
also demonstrated that Hey2-Hes1 binding was abrogated with the
dose-dependent increase of Id4 (Figure 6C, lane 5 and lane 6). Taken
together, we confirmed that Id4 reverses the transcriptional repression
by Hey2-Hes1 heterodimer in a dose-dependent manner.
Id4/Hey2 complex indirectly enhances Runx2
transcriptional activity
The presence of inactive osteoblasts (Figure 5I and 5R) in the
bone tissues of the Id4
2/2 mice let us assume that Id4 may affect
Figure 3. Id4 promotes osteoblast differentiation in ST2 cells. (A) Western blotting of anti-Id4 antibody using ST2 nuclear extract. TFIID was
detected as a loading control. Specific reduction of Id4 expression at day 2 after induction of ST2 cells treated with Id4 siRNA (siId4) for osteoblast
differentiation. (B,C) Decrease in ALP activity (B) and Bglap1 expression (C) at day 6 after induction of osteoblast differentiation in ST2 cells treated
with siId4 as compared to the negative control. (D) Western blotting of anti-Id4 antibody using ST2 cell lysate, infected with Id4 retrovirus or control
retrovirus (control). b-actin was detected as a loading control. (E,F) Increase in ALP (E) and Bglap1 (F) expression at day 4 after infection with Id4 virus
as compared to the control virus in non-induced ST2 and ST2 osteoblast. Relative expression levels of ALP and Bglap1 mRNA were measured by qRT-
PCR. qRT-PCR data were subjected to Student’s t-tests. Each error bar represents the mean 6 SE of triplicates. *p,0.05 versus control, **p,0.01
versus control.
doi:10.1371/journal.pgen.1001019.g003
Id4 Promotes Osteoblast Differentiation
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molecule [20–22]. Osteoblast marker gene Bglap1 expression level
decreased not only in primary osteoblasts but also in embryonic
day18.5 (E18.5) limb of Id4
2/2 mice (Figure S5A and S5B).
Bglap1, a target gene of Runx2 has an E-box element other than
osteoblast-specific element 2 (OSE2), which binds Runx2 to the
promoter [23]. Therefore, we measured the promoter activity to
examine the influence of Id4 on Bglap1 E-box promoter-dependent
transcriptional activity of Runx2. Although the suppression of
Bglap1 promoter activity by addition of Hes1 and Hey2 was not
detected, a dose-dependent increase of transcriptional activity by
Id4 was observed when testing the OSE2 element-containing
promoter. When using the promoter without OSE2 the increase in
transcriptional activity was not seen (Figure 7A). Since direct
interaction between Id4 and Runx2 was ruled out experimentally
(data not shown), Id4 may indirectly influence Runx2 transcrip-
tional activity through Hes1. Hes1 is known to stimulate the
transcriptional activity of Runx2 protein by increasing its stability
during osteoblast differentiation [24]. We also confirmed that the
addition of Hes1 stabilizes Runx2 protein. Interestingly, the
addition of Id4 further increased the stabilization and accumula-
tion of Runx2 (Figure 7B). Taken together, it appears that Id4
enhances Runx2 transcriptional activity through stabilization of
Runx2 protein.
Taking into account the timing of the elevated Id4 expression
(Figure 2C and Figure S2A), our results strongly suggest that Id4 is
indirectly driving the Hes1-mediated Runx2 stabilization during
osteoblast differentiation. The facts that both Hes1 and Hey2 bind
to the OSE2 element-containing Bglap1 promoter region assessed
by ChIP-qPCR, and that the amount of bound Hes1 and Hey2
decreased in ST2 osteoblasts (Figure 7C) further support this idea.
However, the exact binding site of Hes1-Hey2 heterodimer
remains to be identified. The proposed mechanism of Id4 action
during osteoblast differentiation is illustrated in Figure 7D.
Id4
2/2 mice showed increased adipocytes
Id4 knockdown promoted adipocyte differentiation in ST2 cells
(Figure 4B–4E). Histological analysis of Id4
2/2 tibia bones
revealed elevated numbers of adipocytes in epiphyseal bone
marrow of tibia compared to Id4
+/+ mice (Figure 8A–8D). The
entire analyzed area of epiphyseal tibia bone marrow was
occupied by adipocytes in Id4
2/2 mice (Figure 8E). Moreover,
Pparc2 expression levels were also increased in bone marrow cells
of femur and tibia of Id4
2/2 mice (Figure 8F). In comparison to
Id4
+/+ mice, the number of adipocytes in the lateral calvaria was
markedly increased in Id4
2/2 mice (Figure 5K). These aberrant
traits observed in Id4
2/2 mice implicate Id4 as a crucial molecule
in the lineage choice of MSCs differentiating into either osteoblasts
or adipocytes (Figure 8G).
Discussion
In this study, we have delineated clusters of transcription factors
that act as key regulators in the osteoblast and adipocyte
differentiation network. The observation of sometimes disparately
regulated transcription factors, led us to hypothesize a molecular
Figure 4. Id4 weakly suppresses adipocyte differentiation in ST2 cells. (A) Western blotting of anti-Id4 antibody using ST2 nuclear extract.
TFIID was detected as a loading control. Specific reduction of Id4 expression at day 2 after induction of ST2 cells treated with siId4 for adipocyte
differentiation. (B,C) Increase in Pparc2 (B) and Adipoq (C) expression at day 1 after induction of adipocyte differentiation and treatment with siId4.
Relative expression levels of Pparc2 and Adipoq mRNA were measured by qRT-PCR. (D) Oil Red O staining of ST2 cells at day 4 after induction of
adipocyte differentiation in presence of control or siId4. Original magnification: 6200; bar=100 mm. (E) Lipid content of ST2 cells measured as
triglyceride level at day 5 after adipogenic induction in presence of control or siId4. (F) Western blotting of anti-Id4 antibody using Cos7 cell lysate,
transfected with Id4 expression vector or empty vector (Vector) as a control. b-actin was detected as a loading control. (G) Lipid content of ST2 cells
transfected with Id4 expression vector or empty vector measured as triglyceride level at day 5 after adipogenic induction. qRT-PCR and lipid content
data were subjected to Student’s t-tests. Each error bar represents the mean 6 SE of triplicates. *p,0.05 versus control and ***p,0.005 versus
control.
doi:10.1371/journal.pgen.1001019.g004
Id4 Promotes Osteoblast Differentiation
PLoS Genetics | www.plosgenetics.org 7 July 2010 | Volume 6 | Issue 7 | e1001019Figure 5. 4-week-old Id4 knockout (Id4
2/2) mice show disturbance in growth and impaired osteoblast differentiation. (A) Tissue
distribution of Id4 mRNA in C57BL/6J male mice was measured by qRT-PCR. Brown adipose tissues; BAT, White adipose tissues; WAT. (B,C) Body
length (B) and body weight (C) of wild-type (Id4
+/+) and Id4
2/2 mice. (D,E,H,I) Villanueva staining of the 6
th lumbar bone of Id4
+/+ mice (D,H) and Id4
2/2
mice (E,I). Red and white arrowheads indicate active cuboidal-shaped osteoblasts (type II osteoblasts) and flattened resting osteoblasts (type IV
Id4 Promotes Osteoblast Differentiation
PLoS Genetics | www.plosgenetics.org 8 July 2010 | Volume 6 | Issue 7 | e1001019switch function that promotes lineage-specific differentiation (e.g.
osteoblast differentiation) and inhibits alternative differentiation
pathways (e.g. adipocyte differentiation). To substantiate the
hypothesis, we clustered gene expression profiles during osteo-
blast/adipocyte differentiation and identified Id4 as a candidate
regulator ofcelllineage choice. Idfamilymembers Id1–4 also belong
to the bHLH superfamily, but lack the DNA binding domain.
Heterodimerization of Id proteins with other bHLH proteins
facilitates dominant negative regulation. A study by Bedford et al.
using Id4
2/2 mice established Id4 as a regulator of proliferation and
differentiation of neural precursor cells [17]. Until now, however,
bone and skeletal abnormalities of this mouse model have not been
reported. Besides our report, expression profile studies of BMP-
independent osteoblast differentiation of human MSCs and BMP2-
induced osteoblast differentiation using calvarial cells derived from
Runx2-deficient mice [25,26] demonstrated that the expression level
of Id4 gene increases during osteoblast differentiation. These results
suggest that Id4 plays an important role during osteoblast
differentiation. Yet, the precise mechanism of Id4 action and
regulation remained enigmatic. We have clearly demonstrated by in
vitro and in vivo loss-of-function analysis that Id4 enhances osteogenic
differentiation. Furthermore, we established a model of Id4 playing
the role of molecular switch in osteoblast differentiation of MSCs
(Figure 7D). Id4 expression increases upon BMP-induced osteoblast
differentiation. Accumulating Id4 proteins transiently interact with
Hes1-bound Hey2, thus triggering the release of Hes1 and the
formation of Id4-Hey2 heterodimers and Hes1-Runx2 complexes.
The binding of Hes1 to Runx2 potentiates the transcriptional
activity of Runx2 and therefore osteoblast differentiation.
Hes1 and Hey2 are the target molecules of Notch signaling [19].
Until now, the relationship between Notch and BMP signaling
pathways has been characterized by conflicting reports. On one
hand experiments using ST2 cells showed that Notch1 suppresses
the BMP-induced differentiation into osteoblasts [27]. On the other
hand, Nobta et al. [28] reported that Notch signaling enhances
BMP-induced osteoblast differentiation of C2C12 or MC3T3-E1
cells. At this point, there are insufficient data to resolve the
controversy about the role of Notch signaling in BMP-induced
osteoblast differentiation. However, our model (Figure 7D) may
help to clarify the function of Notch signaling. In the absenceof Id4,
Hes1-Hey2 heterodimer just occupies the promoter region of the
Runx2 target gene, whereas in the presence of Id4, Id4-Hey2 and
Hes1-Runx2 complexes increase simultaneously. The concomitant
increase of both complexes enhances the transcriptional activity of
Runx2. Thus, we propose that availability and concentration of Id4
might account for the disparate roles of Notch signaling.
In Id4
2/2 mice, the drop of calvarial BFR is consistent with the
phenotype of Id1/Id3 heterozygous knockout mice. After BMP
stimulation, Id1/Id3 heterozygous knockout mice-derived calvarial
cells showed reduced proliferation activity compared to calvarial
cells derived from wild-type mice [29]. Thus, the decreased rate of
calvarial bone formation in Id4
2/2 mice might be the conse-
quence of reduced osteoblast proliferation. The expression levels of
Id1and Id2 were also up-regulated in the early stage of BMP4-
induced osteoblast differentiation (Figure 2A). Indeed, it has been
reported that Id1 is an important early gene in osteoblasts after
BMP stimulation [30,31]. Although the biological significance of
Id1 in the regulation of MSCs has to be elucidated in future
studies, in ST2 cells, expression levels of Id1 and Id2 immediately
returned to base levels (Figure 2C). In contrast, Id4 expression
levels in ST2 and 3T3-E1 cells continued to rise until 4 days
(Figure 2C and Figure S2A) and 7days, respectively [32].
Systemic hormones and local cytokines are known to be central
regulators of bone formation. Serumlevelsof growth hormone(IGF1)
and thyroid hormones (T3 and T4) did not change significantly
between Id4
+/+ and Id4
2/2 mice (data not shown). Hence, impaired
bone formation is most likely independent of hormonal factors and
caused by repression of osteoblast differentiation.
Since the expression level of Id4 decreases during adipocyte
differentiation (Figure 2C and Figure S2B), Id4 was believed to
inhibit MSCs differentiation into adipocytes. We demonstrated
that Id4 suppression promoted adipocyte differentiation
(Figure 4B–4E and Figure 8A–8E), but Id4 overexpression slightly
decreased lipid accumulation level in ST2 adipocytes (Figure 4G).
In an effort to shed light on the molecular mechanism, we assayed
the expression level of Pparc2, a master regulator of adipocyte
differentiation. Pparc2 expression increased in adipogenic-induced
ST2 cells when Id4 was knocked down (Figure 4B) and in bone
marrow cells of femur and tibia of Id4
2/2 mice (Figure 8F).
However, the results of luciferase reporter assays ruled out effects
of Id4 on the promoter activity of Pparc2 (data not shown). Pparc2
down-regulation by Id4 might involve a yet unknown, indirect
regulatory mechanism. We noticed that the number of osteoclasts
increased in the tibial epiphyseal regions and the 6
th lumbar
vertebra (data not shown). In view of an earlier report on Pparc
promoting osteoclast differentiation by activating c-fos [33], we
interpret the increased number of adipocytes and osteoclasts in 6
th
lumbar and tibial bone of Id4
2/2 mice as a result of indirect
activation of Pparc1 and/or Pparc2 transcriptional activity by lack
of Id4. To corroborate these assumptions, additional analyses of
the relationships and interactions of Id4, Pparc and c-fos in
context of adipocyte and osteoclast differentiation are necessary.
In summary, delineating clusters of transcription factors is a
powerful strategy to identify cell fate-determining members of
regulatory networks. Concerted application of our genome-wide
expression profiling analyses and validation of transcription factor
candidate regulators synthesize knowledge of specific molecular
mechanism underlying osteoporosis and/or metabolic disease. In
case of Id4, our findings reflect the potential pen-ultimate position
of Id4 in the Runx2 activation/repression, which permits the
differential integration of various upstream signals. Since BMP
and Notch signaling affect osteoblast differentiation at different
phases of differentiation, modulation of Id4 expression may create
new venues for treating the onset of osteoporosis.
Materials and Methods
Cell culture
ST2 cells were obtained from RIKEN BioResource Center
(BRC, Tsukuba, Japan) and cultured as described [34]. Primary
osteoblasts), respectively. (F,G,L,M) Bone formation rate (BFR) in the lumbar regions (F,G) and the lateral calvarial bone (L,M) of Id4
+/+ (F,L) and Id4
2/2
(G,M) mice. The BFR was measured using fluorescence microscopy following double-staining with tetracycline hydrochloride (blue arrowhead) and
calcein (green arrowhead). Yellow arrowheads indicate adipocytes. (J,K) Villanueva staining of the lateral calvarial bone of Id4
+/+ (J) and Id4
2/2 mice (K).
Black arrowheads indicate osteoblasts. The original magnifications and scale bars of the images are6400 and 50 mm (D–G),6400 and 30 mm (H,I) and
6200 and 50 mm (J–M). (N) Bone volume (BV) to total volume (TV) ratio in the 6
th lumbar bone. (O,P) BFR to bone surface (BS) ratio (O) and mineral
apposition rate (MAR) (P) in the 6
th lumbar bone and lateral calvarial bone. (Q,R) Number of type II osteoblasts (Q) and type IV osteoblasts (R) on the
correspondingarea of the lumbar BS.(S)Osteoid thickness(O. Th)inthelateral calvarialbone.N-S: Id4
+/+ (n=6),Id4
2/2 (n=6).Alldata were subjectedto
Student’s t-tests. Each error bar represents the mean 6 SE. *p,0.05 versus control, **p,0.01 versus control and ***p,0.005 versus control.
doi:10.1371/journal.pgen.1001019.g005
Id4 Promotes Osteoblast Differentiation
PLoS Genetics | www.plosgenetics.org 9 July 2010 | Volume 6 | Issue 7 | e1001019osteoblasts were isolated from Id4
+/+ and Id4
2/2 neonatal
calvarial bone as described previously [35]. Osteogenic differen-
tiation was induced by changing the medium every three days to
culture medium supplemented with 100 ng/ml of bone morpho-
genetic protein 4 (BMP4) (R&D Systems, Mineapolis, MN) and
adipogenic differentiation was induced by changing the medium to
differentiation medium supplemented with 10% fetal bovine
serum (FBS), 0.5 mM 3-isobutyl-1-methlxanthine, 0.25 mM dexa-
methasone, and insulin-transferrin-selenium-X supplement con-
taining 5 mg/ml of insulin (Invitrogen, Carlsbad, CA) and 1 mM
rosiglitazone. After 48 hr, the differentiation medium was replaced
with culture medium supplemented with 10% FBS.
Id4 knockdown by siRNA
siRNA sequences targeting the mouse Id4 transcript were
purchased from Ambion (for adipocyte) and Invitrogen (for
osteoblast). AllStar Negative Control siRNA (QIAGEN, cat. No.,
1027281) and Negative Universal Control Med#2( I n v i t r o g e n ,c a t .
No., 12935-112) was used as a negative control in adipocyte and
osteoblast differentiation, respectively. The sequences of siRNA used
forId4knockdownwereasfollows;sense,CCUUUGUAUUUGAC-
GUGUAtt; antisense, UACACGUCAAAUACAAAGGtt (Ambion,
cat No. AM16704, ID. 159536); for adipocyte differentiation; sense,
UUAAUUUCUGCUCUGGCCCUCCCUU; antisense, AAGG-
GAGGGCCAGAGCAGAAAUUAA (Invitrogen, stealth_455, cat
No. 10620312); for osteoblast differentiation. For siRNA transfection,
a complexof Lipofectamine 2000 (Invitrogen)and 20 nMsiRNAwas
prepared according to the manufacturer’s instruction and directly
mixed with cells in the culture plates. The medium was replaced at 4–
6 hr after transfection with fresh differentiation medium (adipogenic
induction) or 10% FBS supplemented with 100 ng/ml of BMP4
(osteogenic induction).
Lipid assay and Alkaline phosphatase (ALP) staining
Lipid accumulation in adipocytes was detected by using Oil Red
O staining as described previously [36]. The triglyceride content in
adipocytes was determined as follows. ST2 cells were washed with
cold phosphate-buffered saline (PBS) and total lipids were
extracted with chloroform/methanol (2:1, v/v). The lower organic
phase was dried, and the lipids were dissolved in 2-propanol. The
triglyceride content was measured using Triglyceride E-test
(Wako, Japan) according to the manufacturer’s instructions.
Protein concentrations were determined with Quick Start
Bradford Dye Reagent (BIO RAD, 500-0205), using bovine
gamma globulin as standard. ALP staining and measurements
were performed as described previously [34].
Isolation of total RNA and quantitative real-time PCR
(qRT–PCR)
Total RNA was isolated from liver, brain, kidney, thymus,
brown adipose tissue (BAT), heart, white adipose tissue (WAT),
adrenal gland, cortical bone, calvaria, bone marrow and posterior
limb of E18.5 mouse embryo using TRIzol reagent (Invitrogen)
and RNeasy columns (QIAGEN, Hilden, Germany) according to
the manufacturer’s instructions. Bone marrow was obtained by
slicing of the ends of femur and tibia bones and then flushing it out
with PBS using a syringe. Yield and quality of RNA were
determined with a NanoDrop spectrometer (NanoDrop Technol-
ogy, San Diego, CA) and a BioAnalyzer (Agilent Technologies,
Santa Clara, CA). Gene expression levels were measured by qRT-
PCR as described previously [34]. The sequences of forward and
reverse primers used for each gene amplification were as follows;
gapdh, GAPDH_768Fw_qPCR 59-TGGAGAAACCTGCCAAG-
TATG-39, GAPDH_889Rv_qPCR 59-GGAGACAACCTGGT-
CCTCAG-39; Id4, Mm_Id4_532Fw 59-AGGGTGACAGCATT-
CTCTGC-39, Mm_Id4_658Rv 59-CCGGTGGCTTGTTTC-
TCTTA-39; Pparc2, PPARg2Fw 59-ATGGGTGAAACTCTGG-
Figure 6. Id4 interacts with Hey2 and inhibits the suppression
of reporter activity by Hey2/Hes1 complex. (A) Interaction of
FLAG-tagged Id4 (FLAG-Id4) and human influenza hemagglutinin-
tagged Hey2 (HA-Hey2) was confirmed in 293FT cells by immunopre-
cipitation (IP). (B) CV1 cells transfected with 66E-box luciferase reporter,
Hey2 and Hes1 expression vectors and with increasing doses of Id4
expression vector. Luciferase assay data were subjected to Student’s t-
tests. Each error bar represents the mean 6 SE of triplicates. ***p,0.005
versus control. (C) In vitro assay of Id4 dose-dependent attenuation of
Hey2-Hes1 complex interaction. GST-Id4 volume added was 5, 10 and
20 ml, respectively. WB: Western blotting.
doi:10.1371/journal.pgen.1001019.g006
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39; Bglap1, OC(PM15547142)Fw 59-CTCTGTCTCTC TGAC-
CTCACAG-39, OC(PM15547142)Rv 59-GGAGCTGCTGTGA-
CATCCATAC-39; Adipoq, Mm_AdipoQ_298Fw 59-GATGG-
CACTCCTGGAGAGAA-39, Mm_AdipoQ_443Rv 59-GCTTC-
TCCAGGCTCTCCTTT-39.
Expression microarray experiments
RNA was extracted from differentiating ST2 osteoblasts and
adipocytes after induction of differentiation, using PureLink
miRNA Isolation Kit (Invitrogen) according to the manufacture’s
instructions for total RNA purification. Total RNA derived from
ST2 at 0 hr was used as control. Biotin-labeled cRNA was
synthesized as recommended by Affymetrix guidelines. Labeled
samples were hybridized to the Affymetrix GeneChip Mouse
Genome 420 2.0 arrays according to the manufacturer’s protocol.
Scanning and intensity data analysis was preformed as described
elsewhere [37].
Expression profiling analyses in ST2 osteoblast and
adipocyte differentiation
Collected microarray expression data was background-
subtracted, and normalized using the robust multi-array analysis
method [37]. Differentially expressed genes were determined by
selecting expression subgroups that contained the probe sets of
up/down-regulated genes. Genes were considered up-regulated
(down-regulated) if their log2 intensity ratio was greater (less)
than 1 (21), or greater (less) than the mean plus (minus) 3-times
standard deviation. All gene and probe set annotations were
derived from Ensembl release 52. Genes with transcription-
related Gene Ontology (GO) annotations (Table 3) were
considered as transcription factor-coding genes. Genes with
Figure 7. Id4 enhanced Runx2 transcriptional activity through stabilization of Runx2 protein. (A) Relative luciferase activity of Bglap1
promoter in CV1 cells transfected with Runx2, Hes1, Hey2 and Id4 expression vectors. Bglap1 promoter luciferase reporters were used as Runx2-
dependent (2436bp/+1bp) or Runx2-independent (2137bp/+1bp). Luciferase assay data were subjected to Student’s t-tests. Each error bar
represents the mean 6 SE of triplicates. *p,0.05 versus control and ***p,0.005 versus control. +1; transcription start site, bp; base pair. (B) Western
blot analysis of Cos7 whole cell lysate using anti-Runx2, anti-HA and anti-b-actin (loading control) antibodies. The stability of Runx2-Hes1 complex
increased in the presence of Id4. (C) ChIP-qPCR analyses of Hey2 and Hes1 binding onto Bglap1 promoter in ST2 cells at day 4 after induction of
osteoblast differentiation or non-induced ST2 cells. (D) A model of Id4 promoting Runx2-induced osteoblast differentiation.
doi:10.1371/journal.pgen.1001019.g007
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transcription factor-coding genes. Spotfire DecisionSite version
8.1.1 (TIBCO Software, Inc.) was used for hierarchical
clustering and generating the gene expression heat maps.
Luciferase reporter assays
Bglap1 promoter regions were cloned by PCR from the mouse
genome. 66E-box sequence (CGCGTCCACGTGGGGCCAC-
GTGGGGCCACGTGGGGCCACGTGGG GCCACGTGGG-
Figure 8. 4-week-old Id4
2/2 mice show increased adipocytes in bone marrow. (A,B) Villanueva staining of epiphyseal tibia of Id4
+/+ (A) and
Id4
2/2 mice (B). (C,D) The BFR was measured in the tibial epiphysial regions in Id4
+/+ (C) and Id4
2/2 mice (D) using a fluorescence microscopy
following double-staining with tetracycline hydrochloride (blue arrowheads) and calcein (white arrowheads). Yellow arrowheads indicate adipocytes.
The original magnifications and scale bars of the images are 6400 and 100 mm. (E) The total area occupied by adipocytes (Adi.V) in the epiphyseal
tibia bone marrow. Id4
+/+ (n=6), Id4
2/2 (n=6). (F) Pparc2 mRNA expression is significantly elevated in bone marrow cells of Id4
2/2 compared to Id4
+/+
mice. Relative expression levels of Pparc2 mRNA were measured by qRT-PCR. Id4
+/+ (n=9), Id4
2/2 (n=10). All data were subjected to Student’s t-tests.
Each error bar represents the mean 6 SE. *p,0.05 versus control. (G) The role of Id4 in bone formation and bone marrow environment.
doi:10.1371/journal.pgen.1001019.g008
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firefly luciferase gene (derived from pGL4.10, Promega). CV1 cells
were co-transfected with the firefly luciferase reporter vectors,
expression vectors and the internal control Renilla luciferase
vector (pGL4.74, Promega) using Lipofectamine 2000 (Invitrogen).
Luciferase activities were measured with Wallac 1420 Multilabel
counter (PerkinElmer Life and Analytical Sciences, Turku,
Finland). These experiments were performed in triplicate.
Co-immunoprecipitation and GST–pull down assay
Cos7 cells were transfected with FLAG-Id4 expression vector
with either HA tagged expression vector (Hes1, Hey1, Hey2,
Bhlhe40). The extracts from the transfected cells were incubated
with Protein G sepharose beads and precipitated with either anti-
FLAG antibody (SIGMA) or normal mouse IgG (Santa cruz)
overnight at 4Cu. After washing with PBS, bound proteins were
separated by SDS-PAGE followed by Western blot analysis with
anti-HA antibody, anti-FLAG antibody. GST-Id4 expression
vector, Flag-Hey2 expression vector and Flag-empty vector were
expressed in E.coli. The crude extract of GST-Id4 or GST
expressed in E.coli was incubated with glutatihione sepharose
beads for 4 hr at 4Cu. The precipitate was incubated with the
extract of Flag-Hey2 overnight at 4Cu. After washing, the bound
proteins were separated by SDS-PAGE followed by Western blot
analysis with anti-Flag antibody.
Chromatin Immunoprecipitation (ChIP)–qPCR analysis
ChIP was performed as described previously [38]. ST2 cells
were cultured for 4 days with or without 100 ng/ml BMP4,
respectively. The antibodies used for ChIP were anti-Hey2
(Protein Tech Group, cat No. 10597-1-AP), anti-Hes1 (Santa
Cruz, H-140) and normal rabbit IgG (Santa Cruz, sc-2027) as
negative control. Forward and reverse qPCR primer sequences
contained OSE2 of the Bglap1 promoter (Bglap2_ChIP_L789, 59-
GATTGTGGCCTCTCGTC-39;Bglap2_ChIP_R8, 59- ATCG-
GCTACTCTGTGCTCT-39).
Animals
Id4
2/2 mice previously generated by Bedford et al. (2005) were
kindly supplied by Dr. Kondo who received them originally from
Dr. Sablitzky (University of Nottingham). All mice used in this
study were maintained and handled according to the protocols
approved by the Animal Research Committee of Saitama Medical
University.
Bone morphometric measurements
To assess the static and dynamic parameters of bone
histomorphometry, 3 weeks old female mice were labeled with
intraperitoneal injections of 20 mg/kg of tetracycline hydrochlo-
ride (Sigma) at 4 days before sacrifice. Two days before sacrifice,
the mice were injected with 10 mg/kg of calcein (Dojindo Co.,
Kumamoto, Japan). Tibiae and lumbar vertebrae were removed
from each mouse, and fixated with 70% ethanol. The bones were
trimmed to remove the muscle, stained with Villanueva bone stain
for 5 days, dehydrated in graded concentrations of ethanol, and
embedded in methyl-methacrylate (Wako Chemicals, Kanagawa,
Japan) without decalcification. Sagittal plane sections (5 mm thick)
of the lumbar vertebrae were cut using a Microtome (Leica,
Germany). Bone morphometric analyses were performed using a
semi-automatic image analyzing system software (System Supply,
Nagano, Japan) and Optiphot fluorescent microscope (Nikon,
Tokyo, Japan).
Supporting Information
Figure S1 Heat-map of osteoblast differentiation phase-specific
up-regulated transcription factor genes. Transcription factors of
the bHLH family are indicated by purple bars. The column
‘Cluster groups’ shows the gene symbols of up-regulated
transcription factors in time-sequential (chronological) cluster
order. The gene symbols of the up-regulated transcription factors
are listed in the same order as they appear on the image. Phase 1
(1hr; 46 transcription factors): Foxc2, Nfatc1, Hoxb2, Fkhl18,
Table 3. Gene ontology IDs and terms (GO release 2009-01-
25) associated with 1,270 transcription factors of Table 1.
GO ID GO Term
GO:0000156 two-component response regulator activity
GO:0003700 transcription factor activity
GO:0003701 RNA polymerase I transcription factor activity
GO:0003702 RNA polymerase II transcription factor activity
GO:0003704 specific RNA polymerase II transcription factor activity
GO:0003705 RNA polymerase II transcription factor activity, enhancer binding
GO:0003706 ligand-regulated transcription factor activity
GO:0003709 RNA polymerase III transcription factor activity
GO:0003711 transcription elongation regulator activity
GO:0003712 transcription cofactor activity
GO:0003713 transcription coactivator activity
GO:0003714 transcription corepressor activity
GO:0003715 transcription termination factor activity
GO:0003716 RNA polymerase I transcription termination factor activity
GO:0003717 RNA polymerase II transcription termination factor activity
GO:0003718 RNA polymerase III transcription termination factor activity
GO:0008140 cAMP response element binding protein binding
GO:0008148 negative transcription elongation factor activity
GO:0008159 positive transcription elongation factor activity
GO:0016251 general RNA polymerase II transcription factor activity
GO:0016252 nonspecific RNA polymerase II transcription factor activity
GO:0016455 RNA polymerase II transcription mediator activity
GO:0016563 transcription activator activity
GO:0016564 transcription repressor activity
GO:0016565 general transcriptional repressor activity
GO:0016566 specific transcriptional repressor activity
GO:0016943 RNA polymerase I transcription elongation factor activity
GO:0016944 RNA polymerase II transcription elongation factor activity
GO:0016945 RNA polymerase III transcription elongation factor activity
GO:0016986 transcription initiation factor activity
GO:0016987 sigma factor activity
GO:0016988 transcription initiation factor antagonist activity
GO:0016989 sigma factor antagonist activity
GO:0017163 negative regulator of basal transcription activity
GO:0030374 ligand-dependent nuclear receptor transcription
coactivator activity
GO:0030375 thyroid hormone receptor coactivator activity
GO:0030401 transcription antiterminator activity
GO:0030528 transcription regulator activity
GO:0042156 zinc-mediated transcriptional activator activity
doi:10.1371/journal.pgen.1001019.t003
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Hmga2, Dlx3, Gata2, Dlx2, Nr4a3, Axud1, Eaf1, Hipk2,
AC153948.5, Zfx, Cebpb, Grhl1, Smad7, Rel, Maff, Mafk,
Klf16, Id1, Nfil3, Fosl1, Klf5, Npas4, Lmcd1, Atf3, Fosb, Mef2c,
Erf, Mef2a, Atp6v0a1, Srf, Tgif1, Nr4a1 and Junb; phase 2 (6–
24hr; 29 transcription factors); Hey1, Atoh8, Helb, Hdac9, Atf6,
Gcom1, Hoxa1, Prrx1, Tgfb1, Creb3l1, Rbm9, Elk3, C1d, Dlx1,
Pde8a, Hey2, Ets2, Dtna, Smad6, Foxo1, Cux1, Gatad2b, Irf5,
Rfc1, Sp7, Arnt2, Aebp1, Hoxc13 and Aff3; phase 3 (30–48hr; 4
transcription factors): Lef1, Fabp4, Stat5a, Prrx2; phase 4 (4–6d; 7
transcription factors): Hod, Maf, Foxf2, Sox9, Stat1, Foxd1 and
Neo1; phase 5 (8–14d; 24 transcription factors): Stat2, Esr1, Klf9,
Klf13, AC162313.5, Cml3, Pou6f1, Pura, Nfat5, Zfp521, Trib3,
Ddit3, 2210012G02Rik, Clock, Irf7, Nr3c1, Irf9, Zhx2, Sqstm1,
Znfx1, Atf5, Hoxa9, Nr1d2 and Nfe2l1.
Found at: doi:10.1371/journal.pgen.1001019.s001 (1.10 MB TIF)
Figure S2 Id4 expression pattern in ST2 osteoblast (A) and
adipocyte (B) differentiation. Relative expression levels of Id4
mRNA were measured by qRT-PCR.
Found at: doi:10.1371/journal.pgen.1001019.s002 (0.16 MB TIF)
Figure S3 4-week-old Id4
2/2 mice show decrease of growth
plate in tibia. (A,B) Villanueva staining of growth plate of Id4
+/+
(A) and Id4
2/2 (B) mice tibia. The original magnifications and
scale bars of the images are 664 and 500 mm. (C) Growth plate
width in tibia. (D) Longitudinal Growth Rate (Lo. G. R) in tibia.
All data were subjected to Student’s t-tests. ***p,0.005 versus
control. Each error bar represents the mean6SE of Id4
+/+ (n=6)
and Id4
2/2 (n=6), respectively.
Found at: doi:10.1371/journal.pgen.1001019.s003 (2.67 MB TIF)
Figure S4 Id4 associates with Hey2. (A) Isolation of bHLH
transcription factors binding with Id4 was performed by
immunoprecipitation (IP). IP was carried out using anti-FLAG
antibody and Western blot analysis (WB) was performed using
anti-HA antibody. Arrowheads indicate that Hey2 binds with Id4.
(B) Direct interaction of recombinant glutathione S-transferase-
tagged Id4 (GST-Id4) and recombinant FLAG-tagged Hey2
(FLAG-Hey2) was confirmed in vitro. The GST-pull down assay
performed using glutathione sepharose beads bound to recombi-
nant GST-Id4. Recombinant FLAG-Hey2 was detected with anti-
FLAG antibody.
Found at: doi:10.1371/journal.pgen.1001019.s004 (0.22 MB TIF)
Figure S5 Expression level of osteoblast marker in vivo. (A) Ratio
of relative Bglap1 mRNA expression level between osteoblast-
induced POB and non-induced POB from Id4
+/+ and Id4
2/2
neonatal calvarial bone. Id4
+/+ (n=37), Id4
2/2 (n=21). qRT-
PCR data were subjected to Student’s t-tests. **p,0.01 versus
control. (B) Relative expression levels of Id4 and Bglap1 mRNA in
Id4
+/+ and Id4
2/2 mouse embryo (E18.5) posterior limb were
measured by qRT-PCR. Id4
+/+ (n=1), Id4
2/2 (n=4). Each error
bar represents the mean6SE of triplicates.
Found at: doi:10.1371/journal.pgen.1001019.s005 (0.18 MB TIF)
Table S1 List of transcription factors expressed in induced ST2
cells differentiating into osteoblasts or adipocytes. Bhlh members
are indicated using bold type. Arrows indicate up- (q), down-
regulated (Q), or up- and down-regulated (qQ) transcription
factors. No change in expression levels is symbolized by the almost
equal sign (<).
Found at: doi:10.1371/journal.pgen.1001019.s006 (0.10 MB
XLS)
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